Qifeng Wang

2 articles listing Qifeng Wang in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Retraction Note: The LINC01138 drives malignancies via activating arginine methyltransferase 5 in hepatocellular carcinoma Nature Communications
2. Anti-PD-1 plus nab-paclitaxel and bevacizumab for second-line treatment of cancer of unknown primary (Fudan CUP-002): a phase II trial Nature Communications